[
  {
    "ts": null,
    "headline": "GoodRx Stock Tumbles Despite Launching New Retail Pharmacy Platform",
    "summary": "GDRX rolls out a new e-commerce platform connecting users to top retail pharmacies, aiming to boost savings, improve access, and expand its digital health services.",
    "url": "https://finnhub.io/api/news?id=e955d4ce7dbb7bc3dca5b48f1a9b4ebb5522a382d447f2fd2c1cb58423550574",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744127820,
      "headline": "GoodRx Stock Tumbles Despite Launching New Retail Pharmacy Platform",
      "id": 133787126,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "GDRX rolls out a new e-commerce platform connecting users to top retail pharmacies, aiming to boost savings, improve access, and expand its digital health services.",
      "url": "https://finnhub.io/api/news?id=e955d4ce7dbb7bc3dca5b48f1a9b4ebb5522a382d447f2fd2c1cb58423550574"
    }
  },
  {
    "ts": null,
    "headline": "PODD Stock Benefits From the Launch of Omnipod 5 in Canada",
    "summary": "Insulet announces the commercial launch of Omnipod 5 AID system in Canada, with Dexcom G6 and G7 CGM sensor compatibility.",
    "url": "https://finnhub.io/api/news?id=abc5d5bc8b15fc9e267fcb3cbf5a98519fdba74add0a6a9e8cf31112b4fa4efa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744120920,
      "headline": "PODD Stock Benefits From the Launch of Omnipod 5 in Canada",
      "id": 133783210,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Insulet announces the commercial launch of Omnipod 5 AID system in Canada, with Dexcom G6 and G7 CGM sensor compatibility.",
      "url": "https://finnhub.io/api/news?id=abc5d5bc8b15fc9e267fcb3cbf5a98519fdba74add0a6a9e8cf31112b4fa4efa"
    }
  },
  {
    "ts": null,
    "headline": "Telix Announces Cardinal Health for Gozellix Commercial Distribution",
    "summary": "MELBOURNE, Australia and INDIANAPOLIS, April 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as one of its commercial radiopharmaceutical distributors to supply finished unit doses of Gozellix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection), Telix’s next-generation PSMA-PET imaging1 agent for prostate cancer in the United States (U.S.",
    "url": "https://finnhub.io/api/news?id=770b4fe4d64f9c785a367a35ace51aa18bd28427070ccb42b7e33d0ad5d288eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744108200,
      "headline": "Telix Announces Cardinal Health for Gozellix Commercial Distribution",
      "id": 133787128,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "MELBOURNE, Australia and INDIANAPOLIS, April 08, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that it has selected Cardinal Health, Inc. (NYSE: CAH, Cardinal Health) as one of its commercial radiopharmaceutical distributors to supply finished unit doses of Gozellix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection), Telix’s next-generation PSMA-PET imaging1 agent for prostate cancer in the United States (U.S.",
      "url": "https://finnhub.io/api/news?id=770b4fe4d64f9c785a367a35ace51aa18bd28427070ccb42b7e33d0ad5d288eb"
    }
  },
  {
    "ts": null,
    "headline": "2 Reasons to Like CAH (and 1 Not So Much)",
    "summary": "Since April 2020, the S&P 500 has delivered a total return of 87.2%. But one standout stock has nearly doubled the market - over the past five years, Cardinal Health has surged 159% to $127.74 per share. Its momentum hasn’t stopped as it’s also gained 13.4% in the last six months thanks to its solid quarterly results, beating the S&P by 23.9%.",
    "url": "https://finnhub.io/api/news?id=8253c0a7e0ad2c25783182b1226794a75043a263c04e7873ba8b431bd49ac908",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744103425,
      "headline": "2 Reasons to Like CAH (and 1 Not So Much)",
      "id": 133787129,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Since April 2020, the S&P 500 has delivered a total return of 87.2%. But one standout stock has nearly doubled the market - over the past five years, Cardinal Health has surged 159% to $127.74 per share. Its momentum hasn’t stopped as it’s also gained 13.4% in the last six months thanks to its solid quarterly results, beating the S&P by 23.9%.",
      "url": "https://finnhub.io/api/news?id=8253c0a7e0ad2c25783182b1226794a75043a263c04e7873ba8b431bd49ac908"
    }
  }
]